Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression

Detalles Bibliográficos
Autores principales: Matsuki, Ryota, Okano, Naohiro, Hasui, Nobuhiro, Kawaguchi, Shohei, Momose, Hirokazu, Kitahama, Keiichiro, Nagahama, Kiyotaka, Kogure, Masaharu, Suzuki, Yutaka, Nagashima, Fumio, Shibahara, Junji, Mori, Hideaki, Sakamoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267524/
https://www.ncbi.nlm.nih.gov/pubmed/37325496
http://dx.doi.org/10.1159/000527250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267524/
https://www.ncbi.nlm.nih.gov/pubmed/37325496
http://dx.doi.org/10.1159/000527250

Ejemplares similares